Lipocine Cash Flow - Quarterly (NASDAQ:LPCN)

Add to My Stocks
$1.58 $0.01 (0.64%) LPCN stock closing price Sep 18, 2018 (Closing)

The Lipocine cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Lipocine profits and Lipocine debt. Lipocine cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. Lipocine had cash and cash equivalents of $3.21M at the beginning of the quarter and $6.6M at quarter end for 2018 Q2. Lipocine saw a outflow of $-0.12M from investing activities till 2018 Q2.

View and download details of Lipocine cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
-5.98M-2.71M-20.98M-15.65M-10.95M-4.86M-18.97M-16M-12.76M-7M
Depreciation Depletion Amortization Cash-Flow-0.1M-0.04M-0.07M-0.03M-0.01M-----
Net Increase (Decrease) in Assets Liabilities-1.46M-1.51M1.63M1.06M1.84M1.08M-1.93M-1.89M-0.57M-0.33M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net1.05M-2.71M2.21M1.27M-2.37M1.93M1.47M-
Net Cash from (used by) Operating Activities
-6.49M-3.74M-16.7M-12.4M-7.83M-3.13M-18.28M-15.73M-11.68M-6.5M
Increase (Decrease) in Prop Plant And Equipment-------0.05M-0.05M-0.05M-0.03M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments-0.13M-0.91M3.12M4.93M10.11M1.42M3.29M-4.08M-
Other Cash Inflow (Outflow) from Investment Activities-------0.01M-0.01M-0.01M-
Net Cash from (used by) Investment Activities
-0.12M-0.9M3.12M4.93M10.11M1.42M3.22M-4.01M-
Issuance (Purchase) of Equity Shares--11.22M11.17M8.79M3.08M----
Issuance (Repayment) of Debt Securities10M10M--------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
10M10M11.22M11.17M8.79M3.08M----
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
3.39M5.35M-2.34M3.71M11.07M1.37M-14.44M-15.3M-7.63M-5.89M
Cash & Equivalents at Beginning of Year3.21M5.56M20M27.66M45.26M5.37M----
Cash & Equivalents at Year End6.6M8.56M3.21M9.27M16.63M6.93M5.56M4.7M12.37M14.11M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Lipocine stock price history provides insight into historical stock price fluctuations, and Lipocine stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Lipocine is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Lipocine stock price movement.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Lipocine lost $-6.49M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-0.12M for LPCN till last quarter 2018 Q2 report.
  • Cash flow from financing activities shows the flow of cash between Lipocine and its owners and creditors and was $10M till 2018 Q2. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Lipocine Cash Flow